31 March 2022
Our CAR T-cell Research Team talks to Claire Concannon from RNZ's Our Changing World about how we're building the future of cancer treatment in New Zealand.
Dr Patricia Rubio-Reyes, PhD Student Yasmin Nouri and Dr Rachel Perret are part of the Malaghan Institute's Freemasons CAR T-cell Research Programme. Their work, running in parallel to the Institute's CAR T-cell clinical trial, aims to both better understand this groundbreaking therapy at the molecular level, as well as develop ways to improve its safety and widen the scope of the therapy to treat more cancers in the future.
Related articles
Tracking the journey of the shapeshifting bacteria behind stomach cancer
19 November 2025
Celebrating milestones in bringing life-saving cell therapies to New Zealand
12 November 2025
Marsden funding to drive discovery and innovation in cancer, allergy and infectious disease research
5 November 2025
Eradicating H. Pylori bacterial infection to reduce stomach cancer
30 October 2025
Developing next generation CAR T-cell therapies for more equitable cancer care
30 October 2025
Making local impact using global training in liver cancer research
30 October 2025